The DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.
Cancer and the chemokine network
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CXCL1 and 2 are 90% identical by amino-acid sequence and signal through the same receptor CXCR2 (Balkwill, 2004).”
From A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis (2012) · cites this paper as Balkwill, 2004
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Self-citationInternational Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,923
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,413
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,605
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,531
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,547
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4
Petit, I., Szyper‐Kravitz, M., Nagler, A., Lahav, M., Peled, A., Habler, L., Ponomaryov, T., Taichman, R. S., Arenzana‐Seisdedos, F., Fujii, N., et al. (2002) · Nature Immunology · doi:10.1038/ni813 · Cited by 1,331
The origin and function of tumor-associated macrophages
Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., & Ruco, L. P. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90008-u · Cited by 1,088
Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., & Krek, W. (2003) · Nature · doi:10.1038/nature01874 · Cited by 870
Regulation of the Chemokine Receptor CXCR4 by Hypoxia
Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030267 · Cited by 841
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., et al. (1999) · Nature Medicine · doi:10.1038/10552 · Cited by 839
Self-citationControl of TH2 polarization by the chemokine monocyte chemoattractant protein-1
Gu, L., Tseng, S., Horner, R. M., Tam‐Amersdorfer, C., Loda, M. F., & Rollins, B. J. (2000) · Nature · doi:10.1038/35006097 · Cited by 832
CXC chemokines in angiogenesis
Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C., Ehlert, J. E., Burdick, M. D., & Strieter, R. M. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.1.1 · Cited by 822
Lévesque, J.-P., Hendy, J., Takamatsu, Y., Simmons, P. J., & Bendall, L. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15994 · Cited by 760
The significance of cancer cell expression of the chemokine receptor CXCR4
Balkwill, F. R. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.003 · Cited by 759
Self-citationChemokine receptors: multifaceted therapeutic targets
Proudfoot, A. E. I. (2002) · Nature reviews. Immunology · doi:10.1038/nri722 · Cited by 755
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
Liles, W. C., Broxmeyer, H. E., Rodger, E., Wood, B. L., Hübel, K., Cooper, S. H., Hangoc, G., Bridger, G. J., Henson, G. W., Calandra, G., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0663 · Cited by 718
Zou, W., Machelon, V., L’Herminé, A. C., Borvak, J., Mercier‐Nomé, F., Isaeva, T., Wei, S., Krzysiek, R., Durand–Gasselin, I., Gordon, A. N., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1339 · Cited by 678
Helbig, G., Christopherson, K. W., Bhat-Nakshatri, P., Kumar, S., Kishimoto, H., Miller, K. D., Broxmeyer, H. E., & Nakshatri, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300609200 · Cited by 639
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
Rubin, J. B., Kung, A. L., Klein, R. S., Chan, J. A.-W., Sun, Y., Schmidt, K. F., Kieran, M. W., Luster, A. D., & Segal, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235846100 · Cited by 615
HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver
Kollet, Ó., Shivtiel, S., Chen, Y.-Q., Suriawinata, J., Thung, S. N., Dabeva, M. D., Kahn, J., Spiegel, A., Dar, A., Samira, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17902 · Cited by 593
The role of cytokines in classical Hodgkin lymphoma
Skinnider, B., & Mak, T. W. (2002) · Blood · doi:10.1182/blood-2002-01-0099 · Cited by 515
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
Scotton, C. J., Wilson, J. L., Scott, K. A., Stamp, G., Wilbanks, G. D., Fricker, S. P., Bridger, G. J., & Balkwill, F. R. (2002) · PubMed · Cited by 476
Self-citationClercq, E. D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1134 · Cited by 469
Phillips, R. J., Burdick, M. D., Lutz, M., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-071oc · Cited by 468
Lapidot, T., & Kollet, Ó. (2002) · Leukemia · doi:10.1038/sj.leu.2402684 · Cited by 463
Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo
Sun, Y.-X., Wang, J., Shelburne, C. E., Lopatin, D. E., Chinnaiyan, A. M., Rubin, M. A., Pienta, K. J., & Taichman, R. S. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10522 · Cited by 443
The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.
Zeelenberg, I. S., Stalle, L. R.-V., & Roos, E. (2003) · PubMed · Cited by 434
Bachelder, R. E., Wendt, M. A., & Mercurio, A. M. (2002) · PubMed · Cited by 428
Koshiba, T., Hosotani, R., Miyamoto, Y., Ida, J., Tsuji, S., Nakajima, S., Kawaguchi, M., Kobayashi, H., Doi, R., Hori, T., et al. (2000) · PubMed · Cited by 427
Sica, A., Saccani, A., Bottazzi, B., Polentarutti, N., Vecchi, A., Damme, J. V., & Mantovani, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.762 · Cited by 423
Yang, T., Chen, S., Leach, M. W., Manfra, D. J., Homey, B., Wiekowski, M., Sullivan, L., Jenh, C., Narula, S. K., Chensue, S. W., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.445 · Cited by 416
Chemokines and the Molecular Basis of Cancer Metastasis
Murphy, P. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200109133451113 · Cited by 415
Chemokine Receptors in Human Endothelial Cells
Gupta, S. K., Lysko, P. G., Pillarisetti, K., Ohlstein, E. H., & Stadel, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4282 · Cited by 408
Geminder, H., Sagi‐Assif, O., Goldberg, L., Meshel, T., Rechavi, G., Witz, I. P., & Ben‐Baruch, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4747 · Cited by 408
Chemokines: agents for the immunotherapy of cancer?
Homey, B., Müller, A., & Zlotnik, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri748 · Cited by 398
Expression of CC Chemokine Receptor-7 and Regional Lymph Node Metastasis of B16 Murine Melanoma
Wiley, H. E., Gonzalez, E. B., Maki, W. C., Wu, M., & Hwang, S. T. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1638 · Cited by 379
CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival
Zhou, Y., Larsen, P. H., Hao, C., & Yong, V. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206222200 · Cited by 363
Tumour necrosis factor α: a potential target for the therapy of solid tumours
Szlosarek, P. W., & Balkwill, F. R. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01196-3 · Cited by 356
Self-citation(2003) · PubMed · Cited by 355
Regulation of the Macrophage Content of Neoplasms by Chemoattractants
Bottazzi, B., Polentarutti, N., Acero, R., Balsari, A., Boraschi, D., Ghezzi, P., Salmona, M., & Mantovani, A. (1983) · Science · doi:10.1126/science.6828888 · Cited by 352
Murakami, T., Maki, W. C., Cardones, A. R., Fang, H., Tun-Kyi, A., Nestle, F. O., & Hwang, S. T. (2002) · PubMed · Cited by 347
Negus, R. P. M., Stamp, G. W. H., Hadley, J., & Balkwill, F. R. (1997) · Europe PMC (PubMed Central) · Cited by 341
Self-citationAzenshtein, E., Luboshits, G., Shina, S., Neumark, E., Shahbazian, D., Weil, M., Wigler, N., Keydar, I., & Ben‐Baruch, A. (2002) · PubMed · Cited by 335
Epithelial cancer cell migration: a role for chemokine receptors?
Scotton, C. J., Wilson, J. L., Milliken, D., Stamp, G., & Balkwill, F. R. (2001) · PubMed · Cited by 335
Self-citationBarbero, S., Bonavia, R., Bajetto, A., Porcile, C., Pirani, P., Ravetti, J. L., Zona, G., Spaziante, R., Florio, T., & Schettini, G. (2003) · PubMed · Cited by 335
Negus, R. P., Stamp, G. W., Relf, M. G., Burke, F., Malik, S. T., Bernasconi, S., Allavena, P., Sozzani, S., Mantovani, A., & Balkwill, F. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117933 · Cited by 315
Self-citationRole of CXCL1 in tumorigenesis of melanoma
Dhawan, P., & Richmond, A. J. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.1.9 · Cited by 309
Libura, J., Drukała, J., Majka, M., Tomescu, O. A., Navenot, J. M., Kucia, M., Marquez‐Curtis, L. A., Peiper, S. C., Barr, F. G., Janowska‐Wieczorek, A., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0031 · Cited by 303
Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma.
Mashino, K., Sadanaga, N., Yamaguchi, H., Tanaka, F., Ohta, M., Shibuta, K., Inoue, H., & Mori, M. (2002) · PubMed · Cited by 300
Luboshits, G., Shina, S., Kaplan, O., Engelberg, S., Nass, D., Lifshitz-Mercer, B., Chaitchik, S., Keydar, I., & Ben‐Baruch, A. (1999) · PubMed · Cited by 297
Hall, J. M., & Korach, K. S. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0438 · Cited by 295
Kijima, T., Maulik, G., Ma, P. C., Tibaldi, E. V., Turner, R. E., Rollins, B. J., Sattler, M., Johnson, B. E., & Salgia, R. (2002) · PubMed · Cited by 275
Kato, M., Kitayama, J., Kazama, S., & Nagawa, H. (2003) · Breast Cancer Research · doi:10.1186/bcr627 · Cited by 267
A chemokine receptor antagonist inhibits experimental breast tumor growth.
Robinson, S. C., Scott, K. A., Wilson, J. L., Thompson, R. G., Proudfoot, A. E. I., & Balkwill, F. R. (2003) · PubMed · Cited by 258
Self-citationCXCR4/CXCL12 expression and signalling in kidney cancer
Schrader, A. J., Lechner, O., Templin, M. F., Dittmar, K. E. J., Machtens, S. A., Mengel, M., Probst‐Kepper, M., Franzke, A., Wollensak, T., Gatzlaff, P., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600221 · Cited by 254
Balkwill, F. R. (2002) · Seminars in Immunology · doi:10.1016/s1044-5323(02)00127-6 · Cited by 238
Self-citationNesbit, M., Schaider, H., Miller, T. H., & Herlyn, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6483 · Cited by 235
Tumors and inflammatory infiltrates: Friends or foes?
Brigati, C., Noonan, D. M., Albini, A., & Benelli, R. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1015587423262 · Cited by 230
Till, K. J., Lin, K., Zuzel, M., & Cawley, J. C. (2002) · Blood · doi:10.1182/blood.v99.8.2977 · Cited by 222
Egawa, T., Kawabata, K., Kawamoto, H., Amada, K., Okamoto, R., Fujii, N., Kishimoto, T., Katsura, Y., & Nagasawa, T. (2001) · Immunity · doi:10.1016/s1074-7613(01)00185-6 · Cited by 220
Monti, P., Leone, B. E., Marchesi, F., Balzano, G., Zerbi, A., Scaltrini, F., Pasquali, C., Calori, G., Pessi, F., Sperti, C., et al. (2003) · PubMed · Cited by 208
CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma.
Bertolini, F., Dell’Agnola, C., Mancuso, P., Rabascio, C., Burlini, A., Monestiroli, S., Gobbi, A., Pruneri, G., & Martinelli, G. (2002) · PubMed · Cited by 204
Ding, Y., Shimada, Y., Maeda, M., Kawabe, A., Kaganoi, J., Komoto, I., Hashimoto, Y., Miyake, M., Hashida, H., & Imamura, M. (2003) · PubMed · Cited by 201
Overexpression of CCR7 mRNA in nonsmall cell lung cancer: Correlation with lymph node metastasis
Takanami, I. (2003) · International Journal of Cancer · doi:10.1002/ijc.11063 · Cited by 199
Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10
Murakami, T., Cardones, A. R., Finkelstein, S. E., Restifo, N. P., Klaunberg, B. A., Nestle, F. O., Castillo, S. S., Dennis, P. A., & Hwang, S. T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030593 · Cited by 190
Ara, T., Itoi, M., Kawabata, K., Egawa, T., Tokoyoda, K., Sugiyama, T., Fujii, N., Amagai, T., & Nagasawa, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4649 · Cited by 183
Locati, M., Deuschle, U., Massardi, M. L., Martínez, F. O., Sironi, M., Sozzani, S., Bartfai, T., & Mantovani, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3557 · Cited by 181
Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells
Daniel, D., Meyer-Morse, N., Bergsland, E. K., Dehne, K., Coussens, L. M., & Hanahan, D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021047 · Cited by 180
Allavena, P., Sica, A., Vecchi, A., Locati, M., Sozzani, S., & Mantovani, A. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17714.x · Cited by 172
Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells
Jordan, N., Kolios, G. C., Abbot, S. E., Sinai, M. A., Thompson, D. A., Petraki, K., & Westwick, J. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6685 · Cited by 171
The Viral Chemokine Macrophage Inflammatory Protein-II Is a Selective Th2 Chemoattractant
Sozzani, S., Luini, W., Bianchi, G., Allavena, P., Wells, T. N. C., Napolitano, M., Bernardini, G., Vecchi, A., D’Ambrosio, D., Mazzeo, D., et al. (1998) · Blood · doi:10.1182/blood.v92.11.4036 · Cited by 167
Amino-terminally Modified RANTES Analogues Demonstrate Differential Effects on RANTES Receptors
Proudfoot, A. E. I., Buser, R., Borlat, F., Alouani, S., Soler, D. F., Offord, R. E., Schröder, J.-M., Power, C., & Wells, T. N. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32478 · Cited by 153
Ohta, M., Kitadai, Y., Tanaka, S., Yoshihara, M., Yasui, W., Mukaida, N., Haruma, K., & Chayama, K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10705 · Cited by 152
Sica, A., Saccani, A., Bottazzi, B., Bernasconi, S., Allavena, P., Gaetano, B., Fei, F., LaRosa, G., Scotton, C. J., Balkwill, F. R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.733 · Cited by 151
Self-citationCCR5 Expression Influences the Progression of Human Breast Cancer in a p53-dependent Manner
Mañes, S., Mira, E., Colomer, R., Montero, S., Real, L. M., Gómez‐Moutón, C., Jiménez-Baranda, S., Garzón, A., Lacalle, R. A., Harshman, K., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030580 · Cited by 140
Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites.
Milliken, D., Scotton, C. J., Raju, S., Balkwill, F. R., & Wilson, J. L. (2002) · PubMed · Cited by 136
Self-citationCardones, A. R., Murakami, T., & Hwang, S. T. (2003) · PubMed · Cited by 134
CXC Chemokine Receptor 4 Expression and Function in Human Anaplastic Thyroid Cancer Cells
Hwang, J. H., Hwang, J. H., Chung, H. K., Kim, D. W., Hwang, E. S., Suh, J. M., Kim, H., You, K., Kwon, O., Ro, H. K., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021381 · Cited by 125
CTLA-4 regulates cell cycle progression during a primary immune response
Greenwald, R. J., Oosterwegel, M. A., van der Woude, D., Kubal, A., Mandelbrot, D. A., Boussiotis, V. A., & Sharpe, A. H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200202)32:2 · Cited by 120
Self-citationRANTES expression is a predictor of survival in stage I lung adenocarcinoma.
Moran, C. J., Arenberg, D. A., Huang, C. C., Giordano, T. J., Thomas, D. G., Misek, D. E., Chen, G., Iannettoni, M. D., Orringer, M. B., Hanash, S., et al. (2002) · PubMed · Cited by 111
Stromal Cell-Derived Factor-1 as a Chemoattractant for Follicular Center Lymphoma B Cells
Corcione, A., Ottonello, L. C., Tortolina, G., Facchetti, P., Airoldi, I., Guglielmino, R., Dadati, P., Truini, M., Sozzani, S., Dallegri, F., et al. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.8.628 · Cited by 99
Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours
Scotton, C. J., Milliken, D., Wilson, J. L., Raju, S., & Balkwill, F. R. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2020 · Cited by 89
Self-citationBurger, H., Nooter, K., Boersma, A. W. M., van Wingerden, K. E., Looijenga, L. H. J., Jochemsen, A. G., & Stoter, G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990517)81:4 · Cited by 89
Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma
Kleinhans, M., Tun-Kyi, A., Gilliet, M. F., Kadin, M. E., Dummer, R., Burg, G., & Nestle, F. O. (2003) · Blood · doi:10.1182/blood-2002-02-0475 · Cited by 89
PARC/CCL18 Is a Plasma CC Chemokine with Increased Levels in Childhood Acute Lymphoblastic Leukemia
Struyf, S., Schutyser, E., Gouwy, M., Gijsbers, K., Proost, P., Benoît, Y., Opdenakker, G., Damme, J. V., & Laureys, G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63564-x · Cited by 78
Retention of CXCR4 in the endoplasmic reticulum blocks dissemination of a T cell hybridoma
Zeelenberg, I. S., Stalle, L. R.-V., & Roos, E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11330 · Cited by 62
Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase proteinin vivo
Gabay, C., Gigley, J. P., Sipe, J. D., Arend, W. P., & Fantuzzi, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200102)31:2 · Cited by 61
Self-citationSignore, A., Capriotti, G., Scopinaro, F., Bonanno, E., & Modesti, A. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00174-1 · Cited by 16
Billingsley, K. G., Maynard, C. C., Schwartz, D. L., & Dominitz, J. A. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5 · Cited by 11
Stem cells take a shortcut to the bone marrow
Dick, J. E., & Lapidot, T. (2003) · Blood · doi:10.1182/blood-2003-02-0392 · Cited by 6
Flagged first, then by citations
1 of the 102 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Darash-Yahana, M. et al. Human prostate cancer growth, vascularisation and metastasis is stimulated via high expression levels of the chemokine receptor CXCR4. Proc. Am. Assoc. Cancer Res. 44, 789 (2003).
Cited by
Sorted by citations
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Self-citationThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Metadata
- Authors
- Balkwill, F.
- Venue
- Nature Reviews Cancer
- Published
- 2004-07
- Volume
- 4
- Issue
- 7
- Pages
- 540-550
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1986986419
- Cited by
- 2,343
- References
- 102
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 57 · 2023: 82 · 2022: 112 · 2021: 132 · 2020: 122 · 2019: 84 · 2018: 131 · 2017: 127 · 2016: 134 · 2015: 133 · 2014: 152 · 2013: 119 · 2012: 135
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- chemokines, chemokine receptors, carcinogenesis, metastasis, tumor-host interaction, metastatic potential, site-specific metastasis, chemokine receptor antagonists, inflammation, autoimmune disease, cancer therapy
- MeSH terms
- Animals, Antineoplastic Agents, Autoimmune Diseases, Chemotaxis, Leukocyte, Humans, Inflammation, Macrophage Activation, Mice, Nude, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Proteins, Neoplasms, Lymphocytes, Tumor-Infiltrating, Chemokines, Receptors, Chemokine, Xenograft Model Antitumor Assays, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review